Endothelial dysfunction in diabetes
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease. The endothelium controls the tone of the underlying vascular smooth muscle through the production of vasodilator mediators. The endothelium‐derived relaxing factors (EDRF) comprise nitric oxide (NO), prostacyclin, and a still elusive endothelium‐derived hyperpolarizing factor (EDHF). Impaired endothelium‐dependent vasodilation has been demonstrated in various vascular beds of different animal models of diabetes and in humans with type 1 and 2 diabetes. Several mechanisms of endothelial dysfunction have been reported, including impaired signal transduction or substrate availibility, impaired release of EDRF, increased destruction of EDRF, enhanced release of endothelium‐derived constricting factors and decreased sensitivity of the vascular smooth muscle to EDRF. The principal mediators of hyperglycaemia‐induced endothelial dysfunction may be activation of protein kinase C, increased activity of the polyol pathway, non‐enzymatic glycation and oxidative stress. Correction of these pathways, as well as administration of ACE inhibitors and folate, has been shown to improve endothelium‐dependent vasodilation in diabetes. Since the mechanisms of endothelial dysfunction appear to differ according to the diabetic model and the vascular bed under study, it is important to select clinically relevant models for future research of endothelial dysfunction. British Journal of Pharmacology (2000) 130 , 963–974; doi: 10.1038/sj.bjp.0703393
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both hyperglycemia and hyperinsulinemia alter the endothelium,27 disrupting the normal atheroprotective nitric oxide regulatory environment and encouraging a generalized proinflammatory, vasoconstrictive state predisposing to atherothrombosis.27–29”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Impaired endothelium-dependent vasodilation has been demonstrated in various vascular beds of animal models of diabetes and humans with type 1 and type 2 diabetes (80).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441 · cited 1×
“Although AGE formation occurs during the normal ageing process, it is markedly accelerated during diabetes, as a consequence of an increase in substrate, e.g. glucose, and in the prevailing oxidant stress in this disease (Baynes & Thorpe, 1999).”
BackgroundEndothelium‐derived relaxing and contracting factors
Furchgott, R. F., & Vanhoutte, P. M. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.9.2545495 · Cited by 1,993
Self-citationOxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,930
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Wolff, S. P., & Dean, R. T. (1987) · Biochemical Journal · doi:10.1042/bj2450243 · Cited by 1,271
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
Rubanyi, G. M., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.5.h822 · Cited by 1,188
Self-citationBucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Research works printed but not linked: 6
- DE VRIESE A., 1999, Impaired endothelium‐derived hyperpolarizing factormediated renal vasodilatory response in diabetes: restoration with folate, J. Am. Soc. Nephrol., 10, 394A
- FRIEDMAN E.A., 1999, Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications, Diabetes Care, 22, B65
- FULTON D., 1996, Cytochrome P450 arachidonate metabolites: deficit in diabetes mellitus, FASEB J., 9, A113
- QUILLEY J., 1996, NO‐independent coronary vasodilation to bradykinin in diabetes, Hypertension, 28, P178
- 10.2337/diabetes.42.9.1246 · doi:10.2337/diabetes.42.9.1246
- 10.1042/cs19980382 · doi:10.1042/cs19980382
Cited by
Items 101–200 of 1,000
Sugita, H., Fujimoto, M., Yasukawa, T., Shimizu, N., Sugita, M., Yasuhara, S., Martyn, J. A. J., & Kaneki, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411226200 · Cited by 122
Diabetes‐enhanced inflammation and apoptosis – impact on periodontal pathosis
Graves, D. T., Liu, R., & Oates, T. W. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2007.00219.x · Cited by 137
“These complications have been associated with inflammatory pathways that are enhanced in the diabetic state (1, 5, 15, 18, 61, 65).”
BackgroundMicrocirculation and oxidative stress
Crimi, E., Ignarro, L. J., & Claudio Napoli, A. (2007) · Free Radical Research · doi:10.1080/10715760701732830 · Cited by 136
“Endothelial dysfunction with impaired endothelium-dependent vasodilation has been documented in type 1 [122] and type 2 diabetes [123] as well as in the syndrome of insulin resistance [124]; it also plays an important role in the development of macro and microvascular disease [125].”
BackgroundAssociation of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients
Buraczyńska, M., Książek, P., Baranowicz-Gąszczyk, I., & Jóźwiak, L. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl641 · Cited by 136
“Diabetic microvascular complications are the major causes of morbidity and early mortality in diabetes [1,2].”
BackgroundActivities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats
Alıcıgüzel, Y., Küçükçetin, İ. Ö., Aslan, M., & Karayalçın, Ü. (2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(03)00110-0 · Cited by 133
The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes
Schnackenberg, C. G., & Wilcox, C. S. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051859.x · Cited by 133
“Reduced endothelium-dependent vasodilation (EDV) is a common characteristic of the vascular dysfunction and has been demonstrated extensively in both human and animals models of diabete”
BackgroundDing, H., & Triggle, C. R. (2005) · Vascular Health and Risk Management · doi:10.2147/vhrm.1.1.55.58939 · Cited by 132
“…and, although the endothelium has many additional functions beyond the control of vascular tone, this reduced response to acetylcholine serves as an important indicator of vascular dysfunction (De Vriese et al 2000; Pannirselvam et al 2003; Triggle et al 2003; Andrews et al in press).”
BackgroundInfluentialMatsumoto, T., Noguchi, E., Ishida, K., Kobayashi, T., Yamada, N., & Kamata, K. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00486.2008 · Cited by 126
Szerafin, T., Erdei, N., Fülöp, T., Pásztor, E. T., Edes, I. F., Koller, Á., & Bagi, Z. A. (2006) · Circulation Research · doi:10.1161/01.res.0000241051.83067.62 · Cited by 131
Veronelli, A., Mauri, C., Zecchini, B., Peca, M. G., Turri, O., Valitutti, M. T., Dall’Asta, C., & Pontiroli, A. E. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01242.x · Cited by 129
Leo, C., Hart, J. L., & Woodman, O. L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01023.x · Cited by 128
“These observations are consistent with several other studies that have demonstrated that diabetes causes vascular oxidant stress and causes endothelial dysfunction in either large conduit or resistance vasculature (De Vriese et al., 2000; Xu and Zou, 2009).”
BackgroundResultThe Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications
Dal-Ros, S., & Sigrist, S. (2016) · Diseases · doi:10.3390/diseases4030024 · Cited by 128
“In a healthy artery, vasodilators factors such as nitric oxide (NO), endothelium-derived hyperpolarizing factor (EDHF), and prostacyclin (PGI2) play a key role in homeostasis.”
BackgroundInfluentialFélétou, M., Huang, Y., & Vanhoutte, P. M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0812-6 · Cited by 128
“These dysfunctions are again generally associated with the over-generation of reactive oxygen species, lipid peroxidation, and elevated production of adhesion molecules [14, 50].”
BackgroundSelf-citationInflammation and thrombosis in diabetes
Hess, K., & Grant, P. (2011) · Thrombosis and Haemostasis · doi:10.1160/ths10-11-0739 · Cited by 119
“In diabetes, vasoconstrictive, pro-thrombotic effects dominate, and hyperglycaemia and insulin resistance play a crucial role by inhibiting NO production and increasing ROS production, leading to an increased expression of pro-inflammatory cytokines and platelet adhesion molecules (68).”
BackgroundMatsumoto, T., Kobayashi, T., & Kamata, K. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00954.2002 · Cited by 126
“Diabetes mellitus is associated with vascular complications, including an impairment of vascular responsiveness to neurotransmitters in the macro- and microvasculature (15).”
BackgroundDhar, A., Dhar, I., Desai, K. M., & Wu, L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01017.x · Cited by 125
“…(De BJP British Journal ofPharmacology DOI:10.1111/j.1476-5381.2010.01017.x www.brjpharmacol.org British Journal of Pharmacology (2010) 161 1843–1856 1843© 2010 The Authors British Journal of Pharmacology © 2010 The British Pharmacological Society Vriese et al., 2000; Potenza et al., 2009).”
BackgroundInfluentialGabryelska, A., Łukasik, Z. M., Makowska, J. S., & Białasiewicz, P. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00635 · Cited by 125
“Endothelial damage by factors such as constantly elevated blood glucose (91), cigarette smoke chemicals (92), disrupted lipids homeostasis (93), turbulent blood flow, or inflammatory cytokines (94) causes persistent platelet activation and hyperaggregability.”
BackgroundWauters, A., Dreyfuss, C., Pochet, S., Hendrick, P., Berkenboom, G., van de Borne, P., & Argacha, J.-F. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00991 · Cited by 115
“We have demonstrated the preeminent place of the NO pathway as the final common pathway leading to impaired endothelial-dependent vasodilation after pollution exposure, as is the case for most of the conventional cardiovascular risk factors.(24,44,45) In addition to the key role of oxidative stress, other possible pat…”
BackgroundMartín, R. S., & Sobrevía, L. (2005) · Placenta · doi:10.1016/j.placenta.2005.01.011 · Cited by 123
“Gestational diabetes is characterized by altered D-glucose metabolism and abnormal regulation of the vascular tone [7e15], and patients with this disease exhibit reduced endothelium dependent vasodilatation due to vascular dysfunction [16,17].”
BackgroundForkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy
Kandula, V., Kosuru, R., Li, H., Yan, D., Zhu, Q., Lian, Q., Ge, R., Xia, Z., & Irwin, M. G. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0361-1 · Cited by 122
“Endothelial dysfunction has been revealed in both type 1 and type 2 diabetic patients [109, 110] as well as in several animal models of diabetes [111].”
BackgroundReversibility of endothelial dysfunction in diabetes: role of polyphenols
Suganya, N., Bhakkiyalakshmi, E., Sarada, D. V. L., & Ramkumar, K. M. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516001884 · Cited by 113
“kinase C (PKC) pathway, the hexosamine pathway and the sorbitol pathway((24)), in addition to the generation of methylglyoxal and advanced glycation end products (AGE).”
Erdei, N., Tóth, A., Pásztor, E. T., Papp, Z., Édes, I., Koller, A., & Bagi, Z. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00389.2006 · Cited by 106
Effects of α‐lipoic acid on endothelial function in aged diabetic and high‐fat fed rats
Sena, C. M., Nunes, E., Louro, T., Proença, T., Fernandes, R., Boarder, M. R., & Seiça, R. M. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707474 · Cited by 109
“Hyperlipidaemia and diabetes have been previously shown to induce endothelial dysfunction and increase neointimal formation in human and animal models British Journal of Pharmacology (2008) 153 894–906 (De Vriese et al., 2000; Reis et al., 2000).”
BackgroundLucchesi, P. A., Belmadani, S., & Matrougui, K. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000160214.40855.79 · Cited by 104
Booth, G., Stalker, T. J., Lefer, A. M., & Scalia, R. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.6.e848 · Cited by 111
“Thus several mechanisms of endothelial dysfunction have been reported, including impaired signal transduction or substrate availability, impaired release of NO, increased degradation of NO, enhanced release of endothelium-derived constricting factors, and decreased sensitivity of vascular smooth muscle cells to NO (11…”
BackgroundAugmented Contractile Response of Vascular Smooth Muscle in a Diabetic Mouse Model
Okon, E. B., Szado, T., Laher, I., McManus, B., & van Breemen, C. (2003) · Journal of Vascular Research · doi:10.1159/000075238 · Cited by 106
“Attenuation of both these effects could contribute to the augmented vasoconstriction in vivo. However, increased vasoconstriction of diabetic tissue to different stimuli has been observed in organ bath studies where tissues were free of the influence of insulin [ , , , , ,”
BackgroundYeung, D. K. Y., Leung, S. W. S., Xu, Y. C., Vanhoutte, P. M., & Man, R. Y. K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.078 · Cited by 118
Self-citationCOX-mediated endothelium-dependent contractions: from the past to recent discoveries
Wong, M. S.-K., & Vanhoutte, P. M. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.127 · Cited by 105
Self-citationThomas, G. N., Chook, P., Qiao, M., Huang, X. S., Leong, H. C., Celermajer, D. S., & Woo, K. S. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000118015.26978.07 · Cited by 118
El-Daly, M., Pulakazhi Venu, V. K., Saifeddine, M., Mihara, K., Kang, S., Fedak, P. W. M., Alston, L. A., Hirota, S. A., Ding, H., Triggle, C. R., et al. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.06.006 · Cited by 117
N., C., & J., C. (2002) · Diabetologia · doi:10.1007/s00125-002-0975-6 · Cited by 116
“In Type I, Type II diabetes and insulin resistance syndrome, there is evidence that the release and/or bioavailability of NO are diminished [9, 10].”
BackgroundTsuneki, H., Sekizaki, N., Suzuki, T., Kobayashi, S., Wada, T., Okamoto, T., Kimura, I., & Sasaoka, T. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.006 · Cited by 116
Association of Glycemic Control with Risk of Erectile Dysfunction in Men with Type 2 Diabetes
Lu, C.-C., Jiann, B.-P., Sun, C.-C., Lam, H.-C., Chu, C.-H., & Lee, J.-K. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01219.x · Cited by 104
Oxygen radicals in cardiovascular–renal disease
Schnackenberg, C. G. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00133-9 · Cited by 113
Ellis, A., & Triggle, C. R. (2003) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y03-106 · Cited by 111
Endothelial dysfunction in diabetes: multiple targets for treatment
Ding, H., & Triggle, C. R. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0807-3 · Cited by 110
“Of interest, however, is that most studies, except those in advanced diabetes, indicate that endothelium-independent relaxation to NO, such as that induced by sodium nitroprusside, is unaffected by diabetes clearly suggesting that endothelial dysfunction precedes changes in regulation of vascular smooth muscle vasodil…”
BackgroundResultInfluentialIntravitreal anti-VEGF agents and cardiovascular risk
Porta, M., & Striglia, E. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-019-02253-7 · Cited by 110
Ahmad, F., Sattar, M. Z. A., Rathore, H. A., Abdullah, M., Tan, S., Abdullah, N. A., & Johns, E. J. (2012) · Renal Failure · doi:10.3109/0886022x.2011.643365 · Cited by 109
Physical Activity and Diabetes Complications in Patients With Type 1 Diabetes
Wadén, J., Forsblom, C., Thorn, L. M., Saraheimo, M., Rosengård-Bärlund, M., Heikkilä, O., Lakka, T. A., Tikkanen, H., Groop, P.-H., & on behalf of the FinnDiane Study Group (2008) · Diabetes Care · doi:10.2337/dc07-1238 · Cited by 108
“Diabetes complications, as well as diabetes itself, are further associated with endothelial dysfunction (9,10), which may impair vasodilatation in exercising skeletal muscle tissue.”
BackgroundKarasu, Ç. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010240 · Cited by 107
“The main reasons for the diabetes- induced increase in OS are; an increased generation of oxygen-derived free radicals through autoxidation of glucose, AGE-formation, increased substrate flux through the polyol pathway, and stimulation of eicosanoid metabolism, sorbitol-DAG metabolism and NOS [4-7,”
BackgroundInfluentialCoronary Artery Revascularization in Patients With Diabetes Mellitus
Armstrong, E. J., Rutledge, J. C., & Rogers, J. H. (2013) · Circulation · doi:10.1161/circulationaha.113.002114 · Cited by 107
“However, in patients with type 2 DM, the production of NO is impaired, leading to a decrease in vasodilation.(17) DM is also associated with increased production of proinflammatory cytokines such as tumor necrosis factor-α and interleukin-6 that bind to endothelial surface receptors and activate nuclear factor-κB to i…”
Heuvelman, V. D., Van Raalte, D. H., & Smits, M. M. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvz323 · Cited by 106
Diabetes impairs arteriogenesis in the peripheral circulation: review of molecular mechanisms
Ruiter, M. S., van Golde, J. C., Schaper, N. C., Stehouwer, C. D. A., & Huijberts, M. S. (2010) · Clinical Science · doi:10.1042/cs20100082 · Cited by 106
Minamiyama, Y., Bito, Y., Takemura, S., Takahashi, Y., Kodai, S., Mizuguchi, S., Nishikawa, Y., Suehiro, S., & Okada, S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110460 · Cited by 106
“In this context, attenuated endothelium-dependent vascular relaxation has been reported in different vascular beds of human and animal models of diabetes (De Vriese et al., 2000).”
BackgroundMatsumoto, T., Kakami, M., Noguchi, E., Kobayashi, T., & Kamata, K. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00229.2007 · Cited by 105
“An accumulating body of evidence indicates that endothelium-dependent relaxation is impaired in several blood vessels in Type 2 diabetes, both in animal models and in patients (6, 22, 27), as well as in Type 1 diabetes (6, 11, 23, 29, 30, 34, 36, 39).”
BackgroundInfluentialShi, Y., & Vanhoutte, P. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.110 · Cited by 104
“Diabetes blunts endothelium-dependent relaxations (De Vriese et al., 2000; Rodrı́guezMañas et al., 2003; Shi et al., 2007a) and facilitates endothelium-dependent contractions (Shi et al., 2007b).”
BackgroundSelf-citationPeiró, C., Lafuente, N., Matesanz, N., Cercas, E., Llergo, J. L., Vallejo, S., Rodríguez‐Mañas, L., & Sánchez‐Ferrer, C. F. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704184 · Cited by 104
“In addition to exhibiting impaired vasoactive function (De Vries et al., 2000), diabetic vessels may undergo changes in their structure due to remodelling processes.”
BackgroundTang, Y., Jacobi, A., Vater, C., Zou, L., Zou, X., & Stiehler, M. (2015) · Stem Cells · doi:10.1002/stem.2005 · Cited by 103
Chiriacò, M., Pateras, K., Virdis, A., Charakida, M., Kyriakopoulou, D., Nannipieri, M., Emdin, M., Tsioufis, K., Taddei, S., Masi, S., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13828 · Cited by 97
“Also, in patients with diabetes, the microvascular damage may be promoted by an altered microvascular response to BP variations caused by an altered function of the autonomic nervous system.(97,98) This may contribute to the development of HMOD together with the microvascular remodelling induced by increased BPV.”
BackgroundPontiroli, A., Pizzocri, P., Koprivec, D., Vedani, P., Marchi, M., Arcelloni, C., Paroni, R., Esposito, K., & Giugliano, D. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500195 · Cited by 88
“Endothelial dysfunction and inflammation, as indicated by abnormal flow-dependent vasodilation and by increased circulating levels of adhesion molecules (ICAM-1 and E-selectin) ( 1 , 2) are known to occur in type 2 diabetes mellitus (T2DM), and allegedly predict systemic atherogenesis (3).”
BackgroundEndothelium-Dependent Hyperpolarization and Endothelial Dysfunction
Félétou, M. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000346 · Cited by 102
Mangoni, A. A., Sherwood, R. A., Asonganyi, B., Swift, C. G., Thomas, S. A., & JACKSON, S. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.08.036 · Cited by 102
“tributing to reduced NO availability and endothelial dysfunction in type 2 diabetes are the co-existence of dyslipidemia, obesity, and hypertension.(19) However, endothelial dysfunction has been also demonstrated in type 2 diabetic patients without hypertension and after adjusting for obesity.”
BackgroundMatsumoto, T., Nakayama, N., Ishida, K., Kobayashi, T., & Kamata, K. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.148718 · Cited by 100
Franzini, L., Ardigò, D., Valtueña, S., Pellegrini, N., Rio, D. D., Bianchi, M. A., Scazzina, F., Piatti, P. M., Brighenti, F., & Zavaroni, I. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.04.001 · Cited by 98
Role of EDHF in type 2 diabetes-induced endothelial dysfunction
Park, Y., Capobianco, S., Gao, X. J., Falck, J. R., Dellsperger, K. C., & Zhang, C. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01261.2007 · Cited by 98
“However, EDHF may play an important role in regulating the vascular tone and reactivity, especially in small resistant vessels when NO-mediated control is compromised (7, 35).”
BackgroundPlayford, D. A., Watts, G. F., Croft, K. D., & Burke, V. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00417-3 · Cited by 98
“The favorable effects of combination therapy on the co-infusions of L-NMMA / ACh, after we inhibited endothelial cyclo-oxygenase with aspirin, points to increased release of endothelialderived hyperpolarizing factor [36].”
BackgroundClozel, M., Hess, P., Qiu, C., Ding, S.-S., & Rey, M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094821 · Cited by 97
Pannirselvam, M., Wiehler, W. B., Anderson, T., & Triggle, C. R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706121 · Cited by 92
“…such as acetylcholine (Ach) is a common feature in both conduit and resistance arteries from experimental models of type I and type II diabetes and the literature has been extensively reviewed (Cosentino & Lüscher, 1998; De Vriese et al., 2000; Pannirselvam et al., 2003a; Triggle et al., 2003).”
BackgroundResultEndothelial dysfunction in pregnancy metabolic disorders
Echeverría, C., Eltit, F., Santibanez, J. F., Gatica, S., Cabello‐Verrugio, C., & Simón, F. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.02.009 · Cited by 96
Gallo, A., Ceolotto, G., Pinton, P., Iori, E., Murphy, E., Rutter, G. A., Rizzuto, R., Semplicini, A., & Avogaro, A. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1123 · Cited by 95
“Diabetes 54:1123–1131, 2005 Substantial clinical and experimental evidence suggests that diabetes causes endothelial dysfunction (1): this condition includes decreased endotheliumdependent vasorelaxation, increased leukocyteendothelial cell adhesion, and increased vascular permeability (2–4).”
BackgroundPharmacological approach to diabetic retinopathy
Cruz, J. P. D. L., Correa, J. A. G., Guerrero, A., & Cuesta, M. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.432 · Cited by 95
“Third stage: failure of retinal vascular function Endothelial dysfunction, by causing biochemical imbalances, is considered the fundamental cause of the lesions that appear in diabetic retinopathy [4,9,29,54,57].”
BackgroundLei, Y.-C., Hwang, J., Chan, C., Lee, C.-T., & Cheng, T. (2005) · Environmental Research · doi:10.1016/j.envres.2005.03.011 · Cited by 95
Price, K. D., Price, C. S. C., & Reynolds, R. D. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00569-x · Cited by 95
“[5] Vriese AD, et al.”
BackgroundTsuboi, S., Miyauchi, K., Kasai, T., Ogita, M., Dohi, T., Miyazaki, T., Yokoyama, T., Kojima, T., Yokoyama, K., Kurata, T., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-0730 · Cited by 94
Popov, D. (2010) · International Journal of Diabetes Mellitus · doi:10.1016/j.ijdm.2010.09.002 · Cited by 94
“dowed with specific receptors, and transendothelial channels [79].”
BackgroundReduced Leg Blood Flow during Submaximal Exercise in Type 2 Diabetes
Lalande, S., Gusso, S., Hofman, P. L., & Baldi, J. C. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318161aa99 · Cited by 95
“derived free radicals, and the formation of advanced glycation end products (5,6,13,30).”
BackgroundCyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers
Graupera, M., García‐Pagán, J. C., Parés, M., Abraldeṣ, J. G., Rosello, J., Bosch, J., & Rodés, J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00347-7 · Cited by 94
Coronary microvascular dysfunction in diabetes mellitus: A review
Picchi, A., Capobianco, S., Qiu, T., Focardi, M., 邹晓琴, Cao, J.-M., & Zhang, C. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i11.377 · Cited by 94
Behnke, B. J., Kindig, C. A., McDonough, P., Poole, D. C., & Sexton, W. L. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00059.2002 · Cited by 92
“Moreover, it is known that streptozotocin-induced diabetes in rats elicits marked skeletal muscle structural (7, 19, 27), hemodynamic (8, 12, 19), and metabolic perturbations (6, 7).”
BackgroundInfluentialVriese, A. S. D., de Voorde, J. V., Blom, H. J., Vanhoutte, P. M., Verbeke, M., & Lameire, N. H. (2000) · Diabetologia · doi:10.1007/s001250051502 · Cited by 93
Self-citationPlatelet‐Activation Mechanisms and Vascular Remodeling
Rubenstein, D. A., & Yin, W. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170049 · Cited by 92
Couture, R., & Girolami, J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.045 · Cited by 92
Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes
Beleznai, T., Feher, A., Spielvogel, D., Lansman, S. L., & Bagi, Z. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00831.2010 · Cited by 90
Sugiyama, T., Kobayashi, M., Kawamura, H., Li, Q., & Puro, D. G. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1062 · Cited by 92
“Damage to the endothelium can result in a breakdown of the blood–retinal barrier and a loss of vision due to edema within the retina.(4) At present, the mechanisms by which diabetes induces apoptosis in the retinal microvasculature remain uncertain, although oxidative stress, formation of advanced glycation end produc…”
Ungvari, Z. I., Pacher, P., Kecskemeti, V., Papp, G., Szollár, L., & Koller, A. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00106-6 · Cited by 91
Glycaemic Control and Vascular Complications in Diabetes Mellitus Type 2
Maranta, F., Cianfanelli, L., & Cianflone, D. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_514 · Cited by 90
Endothelial Dysfunction in Normal and Abnormal Glucose Metabolism
Esper, R. J., Vilariño, J. O., Machado, R. A., & Paragano, A. J. (2008) · Advances in cardiology · doi:10.1159/000115120 · Cited by 90
Päivä, H., Lehtimäki, T. J., Laakso, J. T., Ruokonen, I., Rantalaiho, V. M., Wirta, O., Pasternack, A. I., & Laaksonen, R. (2003) · Metabolism · doi:10.1053/meta.2003.50048 · Cited by 90
Yang, Z., Venardos, K. M., Jones, E., Morris, B. J., Chin-Dusting, J. P. F., & Kaye, D. M. (2007) · Circulation · doi:10.1161/circulationaha.106.665836 · Cited by 89
Vanhoutte, P. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.108 · Cited by 89
Self-citationSoriano, L. C., Johansson, S., Stefánsson, B. V., & Rodríguez, L. A. G. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0204-5 · Cited by 88
A novel role for calpains in the endothelial dysfunction of hyperglycemia
Stalker, T. J., Skvarka, C. B., & Scalia, R. (2003) · The FASEB Journal · doi:10.1096/fj.02-1213fje · Cited by 85
“fully explained how hyperglycemia induces vascular dysfunction (7), further investigation in this area is still warranted.”
BackgroundDevelopment of Novel Arginase Inhibitors for Therapy of Endothelial Dysfunction
Steppan, J., Nyhan, D. P., & Berkowitz, D. E. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00278 · Cited by 86
“IMPLICATIONS OF INHIBITORS IN DIABETES MELLITUS Diabetes mellitus has long been shown to be a disease tightly associated with endothelial dysfunction (40).”
BackgroundDiabetes-related alterations in the enteric nervous system and its microenvironment
Bagyánszki, M. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i5.80 · Cited by 71
Li, F. Y. L., Lam, K. S. L., Tse, H.-F., Chen, C., Wang, Y., Vanhoutte, P. M., & Xu, A. (2012) · Circulation · doi:10.1161/circulationaha.112.108159 · Cited by 78
Self-citationSirdah, M. M. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.05.001 · Cited by 85
Majithiya, J. B., & Balaraman, R. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000183720.85014.24 · Cited by 85
“Uncontrolled hyperglycemia causes excessive free radicals generation, which can be reduced by improving the metabolic state in diabetes.(6,21,32) Phenylephrine-induced contraction was significantly increased at early stage of diabetes in rings with intact endothelium but not in endothelium-denuded rings.”
BackgroundMucalo, I., Jovanovski, E., Rahelić, D., Božikov, V., Romić, Ž., & Vuksan, V. V. V. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.08.015 · Cited by 84
“Arterial stiffness and endothelial dysfunction have been clinically linked to decreased NO generation and increased NO inactivation (De Vriese et al., 2000; Ungvari et al., 2010).”
BackgroundShi, Y., Félétou, M., Ku, D. D., Man, R. Y. K., & Vanhoutte, P. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706999 · Cited by 84
“…Journal of Pharmacology (2007) 150, 624–632 & 2007 Nature Publishing Group All rights reserved 0007–1188/07 $30.00 www.brjpharmacol.org Endothelial dysfunction has been reported in diabetic people and experimental animals with diabetes (De Vriese et al., 2000; Schalkwijk and Stehouwer, 2005).”
BackgroundInfluentialSelf-citationBalakumar, P., Chakkarwar, V. A., & Singh, M. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9917-z · Cited by 83
“Vascular endothelium is an interior lining of blood vessels and lies between circulating blood and the vascular smooth muscle cells [2].”
BackgroundBagi, Z., & Koller, A. (2003) · Journal of Vascular Research · doi:10.1159/000068938 · Cited by 79
“Although the multifactorial effects of diabetes on various regulatory functions of blood vessels are still not well understood, it is likely that early alterations in endothelial function contribute to the development of diabetic microangiopathy [ ,”
BackgroundGonzález, M., Rojas, S., Avila, P., Cabrera, L., Villalobos-Labra, R., Palma, C., Aguayo, C. R., Peña, E., Gallardo, V., Guzmán‐Gutiérrez, E., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122398 · Cited by 83
“Elevated extracellular D-glucose increases hCAT-1-mediated L-arginine transport and NO synthesis (the ‘L-arginine/NO pathway’) [14, 15] as well as intracellular ROS generation [16, 17], leading to endothelial dysfunction [2].”
BackgroundMeininger, C. J., Cai, S., Parker, J. L., Channon, K. M., Kelly, K. A., Becker, E. J., Wood, M. K., Wade, L. A., & Wu, G. (2004) · The FASEB Journal · doi:10.1096/fj.04-1702fje · Cited by 80
“iabetes mellitus is characterized by a loss of nitric oxide (NO) bioactivity, resulting in endothelial dysfunction (1).”
BackgroundPaskaloǧlu, K., Şener, G., & Ayanğolu-Dülger, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.002 · Cited by 83
The Calcium-Dependent Protease Calpain Causes Endothelial Dysfunction in Type 2 Diabetes
Stalker, T. J., Gong, Y., & Scalia, R. G. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1132 · Cited by 82
“All of these factors, especially hyperglycemia, have been associated with endothelial dysfunction (2).”
BackgroundInfluentialReactive oxygen‐derived free radicals are key to the endothelial dysfunction of diabetes
Shi, Y., & Vanhoutte, P. M. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00030.x · Cited by 81
“However, the available data are not so conclusive with regard to diabetes.(6) Thus, the present non-exhaustive review will focus on the effect of diabetes on vascular dysfunction, in particular on endothelium-derived vasoactive factors.”
BackgroundSelf-citationTokalı, F. S., Demir, Y., Türkeş, C., Dinçer, B., & Beydemir, Ş. (2023) · Drug Development Research · doi:10.1002/ddr.22031 · Cited by 80
Jokura, H., Watanabe, I., Umeda, M., Hase, T., & Shimotoyodome, A. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.07.005 · Cited by 80
Olukman, M., Orhan, C. E., Çelenk, F. G., & Ülker, S. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2010.02.001 · Cited by 80
Saini, A. K., Kumar, A. H. S., & Sharma, S. S. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.016 · Cited by 80
Metadata
- Authors
- De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., & Vanhoutte, P. M.
- Affiliations
- Institut Servier (FR)
- Ghent University (BE)
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-07
- Volume
- 130
- Issue
- 5
- Pages
- 963-974
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572156
- OpenAlex
- W2007880055
- Cited by
- 1,165
- References
- 114
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 32 · 2023: 15 · 2022: 31 · 2021: 27 · 2020: 44 · 2019: 39 · 2018: 41 · 2017: 31 · 2016: 36 · 2015: 50 · 2014: 56 · 2013: 58 · 2012: 62
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- endothelial dysfunction, diabetes mellitus, diabetic vascular disease, endothelium-derived relaxing factor, nitric oxide, prostacyclin, endothelium-derived hyperpolarizing factor, endothelium-dependent vasodilation, protein kinase C, polyol pathway, glycation, oxidative stress, hyperglycemia, ACE inhibitors, folic acid, vascular smooth muscle
- MeSH terms
- Animals, Biological Factors, Diabetes Mellitus, Endothelium, Vascular, Humans, Nitric Oxide, Protein Kinase C, Vasodilation, Signal Transduction, Endothelins, Glycation End Products, Advanced, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.